Statistics
Publications
10
Citations
552
H-Index
10
Active since
1984
Affiliations
Pfizer (United States)(Current)
Franzanne Vreeland is an author at Pfizer (United States) specializing in pharmacology, medicine, and cancer pharmacology.
Publications per year
1984–2007
10
10
Phase I Trial of Taxotere: Five-Day Schedule
Richard Pazdur, Robert A. Newman, Beth Newman et al. · JNCI Journal of the National Cancer Institute · 1992 · 134 citations
Medicine, Oncology, Pharmacology +16
Absolute bioavailability of letrozole in healthy postmenopausal women
A. Sioufi, N. Gauducheau, V. Pineau et al. · Biopharmaceutics & Drug Disposition · 1997 · 100 citations
Clinical experience with sorbinil—An aldose reductase inhibitor
Norman E. Pitts, Franzanne Vreeland, Gerald L. Shaw et al. · Metabolism · 1986 · 37 citations
1–5 of 10